1 / 25

PRESENTED BY DR.RAMESH SAHARIA. SRIDHAR CANCER CARE CENTRE

SEMINAR ON BREAST CANCER AWARNESS. PRESENTED BY DR.RAMESH SAHARIA. SRIDHAR CANCER CARE CENTRE SRIMANTA SANKERDEV HOSPITAL. INCIDENCE AND PREVELANCE OF BREAST CANCER.

elan
Download Presentation

PRESENTED BY DR.RAMESH SAHARIA. SRIDHAR CANCER CARE CENTRE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SEMINAR ON BREAST CANCER AWARNESS PRESENTED BY DR.RAMESH SAHARIA. SRIDHAR CANCER CARE CENTRE SRIMANTA SANKERDEV HOSPITAL

  2. INCIDENCE AND PREVELANCE OF BREAST CANCER. • Most common cancer in western & 2nd commonest cancer in India,after cervical cancer. • In metropolitan cities, it becomes commonest. • Incidence in India is 28/lac woman. • Incidence in West is 111/lac woman.

  3. RISK FACTORS • Female. M:F 1:100 • Age at menarche. (<12yrs 2 fold+) • Age at menopause.(>55yrs 20%risk compare with <45 yrs) • Age at first live birth .(>30 yrs 2-5 fold+) • Breast feeding.(risk reduction per year of breast feeding is 4.3%) • Nulliparity. • Races/Ethnicity. • Family history/Number of 1st degree relatives with breast cancer.(1.5-3 fold, 5 times if B/L disease) • Current age.

  4. continue:- • Number of previous benign breast biopsies. • Atypical hyperplasia.(4-5 fold) • Known or suspectedBRCA-1/2,p53(56-85% life-time risk of breast cancer) • Prior h/o chest radiation. • H/o current or prior HRT(25-35% excess risk) • Body mass index. • Breast density. • Alcohol consumption.(10-41%risk) • smoking

  5. SYMPTOMS • Breast lump/mass • Chest /axilla lump. • Nipple discharge-blood,serous, pus, greenish. • Asymmetrical thickening/nodularity. • Nipple retraction or excoriation • Skin changes:-peaud’orange,ulcer,erythema, eczema. • Mets. Disease:-headache,breathing bone pain/fracture,abdominal lump ascites.

  6. DIAGNOSIS • Clinical examination. • Mammography. • USG of breast & axilla. • FNAC. • Biopsy. • MRI breast • For mets:- CT brain, chest,abdoman. Bone scan. PET Scan.

  7. .. NOW WHAT ? EARLY WE DIAGNOSED BETTER THE LIFE SMART WOMAN SEE “CAN” IN CANCER LET’S JOIN HANDS TO BEAT BREAST CANCER

  8. BREAST SCREENING AND PREVENTION • Asymptomatic and –ve physical examination. NORMAL RISK. Age >/=20 but <40yrs • Clinical breast exam every 1-3yrs. • Periodic BSE. Age >/=40 yrs. • Annual clinical breast exam. • Annual mammography. • Periodic BSE.

  9. Continue:- • INCREASED RISK. Prior thoracic RT Age <25yrs • Annual CBE. • Periodic BSE. Age >/=25yrs • Annual mammography + CBE 6-12 months. • Periodic BSE. LCIS/Atypical hyperplasia. • Annual mammography + CBE 6-12 months. • Periodic BSE • Consider risk reduction strategies.

  10. Continue:- Strong family history or genetic predisposition. Age<25 yrs • Annual CBE. • Periodic BSE. Age >25 yrs • Annual mammography+CBE 6-12 months. • 5-10 yrs prior to youngest breast cancer cases. • Periodic BSE. • Annual MRI. • Consider risk reduction strategies.

  11. Continue:- Prior history of breast cancer • CBE every 3 months for 1st yrs, every 6 months for next 2 yrs,then annually. • Annual mammography. • Monthly BSE. • Annual pap smear & pelvic exam. In woman on tamoxifen . • Bone scan, PET Scan.

  12. BREAST SELF EXAMINATION

  13. RISK REDUCTION STRATEGIES • BRCA1/2,p53, PTEN gene mutation, strong family h/o breast & ovarian cancer, LCIS, thoracic radiation. • Bilateral breast removal +/-reconstruction.(90%decrease risk). • Bilateral ovary removal.(45-60%decrease risk.) • Risk reduction agents such as tamoxifen,raloxifene,anastrozole, letrozole.(35-40%)

  14. CONCLUSION:- • Earlier we diagnosed breast CANCER better the prognosis & survival. • Delayed is due to lack of awareness, social embarrassment ,fear of procedure,or fear of cancer; woman may be reluctant to undergo screening. • Need of an hour to motivate woman to seek prevention services. • Awareness camp/seminar should be held. • Programs for new screening and treatment approaches.

  15. THANK YOU

  16. INCIDENCE AND PREVELANCE OF CERVICAL CANCER. • Leading causes of cancer death world-wide. • 5 lacs new cases per year. • 3 lacs woman die anually. • Ranks no. one in India. • 1.3 lacs new cases anually in India. • 80-90%of cases occur among woman age 35 or elder,

  17. RISK FACTORS:- • Human papilloma virus infection.(about 80% woman have,<5% develop cervical cancer, but all woman with cervical cancer had HPV). • Smoking. • Early age at first birth. • Use of hormonal contraceptives • Multi-parity. • Impaired immune system(HIV infection). • Multiple partners.

  18. SYMPTOMS:- • Intermentrual bleeding. • Postmenopausal bleeding . • Postcoital bleeding. • Foul smelling discharge. • Pelvic/back pain. • Hematuria /rectal bleeding due to involvment of bladder /rectum.

  19. DIAGNOSIS:- • PAP Smear • Colposcopy / visual inspection. • Biopsy . • USG/CTSCAN Abdomen. • Chest x-ray.

  20. SCREENING AND PREVENTION OF CERVICAL CANCER. • Woman 30yrs or more. • PAP smear every1-3 yrs,if –ve ,can be done as & when required. • Visual inspection of cervix/Colposcopy (iodine/acetic acid stain,if abnormal, cryosurgery/biopsy.) • HPV detection. • Vaccination against HPV in adolscence & young girls. • Once in lifetime screening between 35-40yrs,reduces risk by 25-35%.Further screening at 5yrs intervals can reduces cancer risk.

  21. THANK YOU

More Related